熔点 | 300 °C |
---|---|
分子式 | C5H11NaO3S |
分子量 | 174.194 |
精确质量 | 174.032654 |
PSA | 65.58000 |
LogP | 1.80260 |
外观性状 | 无气味的白色或黄色-白色固体 |
储存条件 |
保持贮藏器密封 放入紧密的贮藏器内,储存在阴凉,干燥的地方 |
稳定性 |
如果遵照规格使用和储存则不会分解 避免接触氧化物 |
水溶解性 | soluble |
分子结构 |
|
计算化学 |
1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:0 3.氢键受体数量:3 4.可旋转化学键数量:4 5.互变异构体数量:无 6.拓扑分子极性表面积65.6 7.重原子数量:10 8.表面电荷:0 9.复杂度:147 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:2 |
更多 |
1.性状:白色粉末 2.密度(g/mL,25/4℃):未确定 3.相对蒸汽密度(g/mL,空气=1):未确定 4.熔点(?C):300 5.沸点(?C,常压):未确定 6.沸点(?C,5.2kPa):未确定 7.折射率:未确定 8.闪点(?C):未确定 9.比旋光度(?):未确定 10.自燃点或引燃温度(?C):未确定 11.蒸气压(kPa,25?C):未确定 12.饱和蒸气压(kPa,60?C):未确定 13.燃烧热(KJ/mol):未确定 14.临界温度(?C):未确定 15.临界压力(KPa):未确定 16.油水(辛醇/水)分配系数的对数值:未确定 17.爆炸上限(%,V/V):未确定 18.爆炸下限(%,V/V):未确定 19.溶解性:溶于水
|
|
戊烷磺酸钠毒性英文版
|
个人防护装备 |
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
危害码 (欧洲) |
Xi:Irritant; |
风险声明 (欧洲) |
R36/38 |
安全声明 (欧洲) |
S37/39-S26-S28-S36/37/39 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
海关编码 | 29041000 |
戊烷磺酸钠上游产品? 5 | |
---|---|
|
|
|
|
戊烷磺酸钠下游产品? 2 | |
|
海关编码 | 2904100000 |
---|---|
中文概述 | 2904100000 仅含磺基的衍生物及其盐和乙酯。监管条件:无。增值税率:17.0%。退税率:9.0%。最惠国关税:5.5%。普通关税:30.0% |
申报要素 | 品名, 成分含量, 用途 |
Summary | 2904100000 derivatives containing only sulpho groups, their salts and ethyl esters。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:5.5%。General tariff:30.0% |
Development and validation of a stability-indicating LC-UV method for the determination of pantethine and its degradation product based on a forced degradation study. J. Pharm. Biomed. Anal. 97 , 141-50, (2014)
Pantethine (d-bis-(N-pantothenyl-β-aminoethyl)-disulfide, PAN), the stable disulfide form of pantetheine, has beneficial effects in vascular diseases being able to decrease the hyperlipidaemia, modera…
|
|
Mixed ion pair liquid chromatography method for the simultaneous assay of ascorbic acid, caffeine, chlorpheniramine maleate, dextromethorphan HBr monohydrate and paracetamol in Frenadol sachets. J. Pharm. Biomed. Anal. 12(1) , 85-90, (1994)
The five active drug substances and two of the excipients present in Frenadol, a cold medication, were separated. The active drug components dextromethorphan HBr monohydrate, ascorbic acid, caffeine, …
|
|
Rapid and selective micellar electrokinetic chromatography for simultaneous determination of amikacin, kanamycin A, and tobramycin with UV detection and application in drug formulations. Electrophoresis 26(4-5) , 947-53, (2005)
A simple and selective micellar electrokinetic chromatography (MEKC) with UV detection is described for simultaneous determination of amikacin, tobramycin, and kanamycin A, performed in Tris buffer (1…
|
|
Sodium 1-pentanesulfonate |
pentane-1-sulfonic acid,sodium-salt |
EINECS 245-208-4 |
1-Pentanesulfonic acid, sodium salt (1:1) |
Sodium Pentanesulfonate |
sodium 1-pentanesulfonic acid |
pentanesulfonic acid na-salt |
IPC-ALKS-5 |
1-pentylsodiumsulfonate |
1-Pentanesulfonic acid sodium salt |
sodium pentane-1-sulfonate |
1-Pentanesulfonic acid,sodium salt |
1-pentanesulfonate,sodium |
MFCD00007541 |
sodium 1-pentane sulfonate |